Other animal experiments have also found that different patterns of stimulation in the depression model, the expression in GFAP, and the number of positive cells of GFAP were found to be down-regulated in key brain regions such as the cortex-marginal system and hippocampus (48). Here, GFAP is linked to depressive symptom measurement.